SLC16A3 and melanoma: The m6A demethylase Alkbh5 has effects on m6A density and splicing events in tumors during ICB therapy and modulates MDSCs accumulation in TME by regulating Mct4/Slc16a3 expression and lactate content of the TME in the employed melanoma and colon syngeneic mouse models (158).